Skip to main content
Conference ProceedingsOPEN ACCESS

Chimeric-antigen receptor T (CAR-T) cell therapy for solid tumor

IOP Conference Series: Materials Science and Engineering (2020) 768(5)
DOI: 10.1088/1757-899X/768/5/052051
1Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Chimeric-antigen receptor T (CAR-T) cell therapy has been researched in the clinical. However, CAR-T cell therapy for solid tumor is faced with lots of challenges such as cytokine storm, how to find the specific antigen and limitation of microenvironment of tumor. In this review, we will discuss the research of CAR-T cell therapy for solid tumors of digestive system, and possible solutions and future direction.

Cite

CITATION STYLE

APA

Ling, H. (2020). Chimeric-antigen receptor T (CAR-T) cell therapy for solid tumor. In IOP Conference Series: Materials Science and Engineering (Vol. 768). Institute of Physics Publishing. https://doi.org/10.1088/1757-899X/768/5/052051

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free